Back to Search
Start Over
Culture Conversion at 6 Months in Patients Receiving Delamanid-containing Regimens for the Treatment of Multidrug-resistant Tuberculosis.
- Source :
- Clinical Infectious Diseases; 7/15/2020, Vol. 71 Issue 2, p415-418, 4p
- Publication Year :
- 2020
-
Abstract
- Delamanid should be effective against highly resistant strains of Mycobacterium tuberculosis , but uptake has been slow globally. In the endTB (expand new drug markets for TB) Observational Study, which enrolled a large, heterogeneous cohorts of patients receiving delamanid as part of a multidrug regimen, 80% of participants experienced sputum culture conversion within 6 months. Clinical Trials Registration. NCT02754765. [ABSTRACT FROM AUTHOR]
- Subjects :
- ANTITUBERCULAR agents
IMIDAZOLES
MICROBIAL sensitivity tests
SPUTUM
TIME
Subjects
Details
- Language :
- English
- ISSN :
- 10584838
- Volume :
- 71
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Clinical Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 144525355
- Full Text :
- https://doi.org/10.1093/cid/ciz1084